Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
Conditions: Binge-Eating Disorder; Obesity Interventions: Drug: NB medication (Naltrexone Bupropion combination); Other: Placebo Sponsors: Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Enrolling by invitation - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Binge Eating Disorder | Bupropion | Diabetes | Eating Disorders & Weight Management | Endocrinology | Obesity | Urology & Nephrology | Wellbutrin